Fluorescence spectroscopy as a novel technique for premarital screening of sickle cell disorders

Photodiagnosis Photodyn Ther. 2021 Jun:34:102276. doi: 10.1016/j.pdpdt.2021.102276. Epub 2021 Mar 30.

Abstract

Spectral diagnostic screening for sickle cell disease was carried out on volunteer blood samples (N = 100). The samples were subjected to different diagnostic methods including conventional complete blood count (CBC), hemoglobin electrophoresis (HBE) and spectral diagnosis. For the spectral diagnostic method, we discriminated three different characteristic spectral features. In total, 15 samples were sickle cell trait (SCT), 34 samples were sickle cell disease (SCD), and the rest of the samples (N = 51) were normal controls. The spectral discrimination of the three different sets of samples was distinguished on the quantification of fluorescent biomolecules such as tyrosine, tryptophan, NADH, FAD, and porphyrins. The results were compared with the conventional standard CBC and capillary electrophoresis findings. The spectral diagnosis method exhibited a sensitivity and specificity greater than 90 % for the tested samples. This technique requires only 5 mL blood samples, has an analysis time of 20 min, exhibits high accuracy and may be used in small clinics in remote villages.

Keywords: Premarital screening; SCD; SCT; Spectral technique and conventional diagnosis.

MeSH terms

  • Anemia, Sickle Cell* / diagnosis
  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents
  • Sickle Cell Trait* / diagnosis
  • Spectrometry, Fluorescence

Substances

  • Photosensitizing Agents